EMAIL THIS PAGE TO A FRIEND

Cell death and differentiation

Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.


PMID 24608791

Abstract

Glioblastoma multiforme patients have a poor prognosis due to therapeutic resistance and tumor relapse. It has been suggested that gliomas are driven by a rare subset of tumor cells known as glioma stem cells (GSCs). This hypothesis states that only a few GSCs are able to divide, differentiate, and initiate a new tumor. It has also been shown that this subpopulation is more resistant to conventional therapies than its differentiated counterpart. In order to understand glioma recurrence post therapy, we investigated the behavior of GSCs after primary chemotherapy. We first show that exposure of patient-derived as well as established glioma cell lines to therapeutic doses of temozolomide (TMZ), the most commonly used antiglioma chemotherapy, consistently increases the GSC pool over time both in vitro and in vivo. Secondly, lineage-tracing analysis of the expanded GSC pool suggests that such amplification is a result of a phenotypic shift in the non-GSC population to a GSC-like state in the presence of TMZ. The newly converted GSC population expresses markers associated with pluripotency and stemness, such as CD133, SOX2, Oct4, and Nestin. Furthermore, we show that intracranial implantation of the newly converted GSCs in nude mice results in a more efficient grafting and invasive phenotype. Taken together, these findings provide the first evidence that glioma cells exposed to chemotherapeutic agents are able to interconvert between non-GSCs and GSCs, thereby replenishing the original tumor population, leading to a more infiltrative phenotype and enhanced chemoresistance. This may represent a potential mechanism for therapeutic relapse.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

277258
2-Methylbutane, anhydrous, ≥99%
C5H12
270342
2-Methylbutane, for HPLC, ≥99.5%
C5H12
59060
2-Methylbutane, analytical standard
C5H12
59070
2-Methylbutane, puriss. p.a., ≥99.5% (GC)
C5H12
15-2230
2-Methylbutane, SAJ first grade, ≥99.0%
C5H12
M32631
2-Methylbutane, ReagentPlus®, ≥99%
C5H12
320404
2-Methylbutane, ReagentPlus®, ≥99%
C5H12
A9400
7-Aminoactinomycin D, ~97% (HPLC), powder
C62H87N13O16
SAB1408977
Anti-EPAS1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2100686
Anti-EPAS1 antibody produced in rabbit, affinity isolated antibody
SAB2701992
Anti-EPAS1 antibody produced in rabbit
SAB1410337
Anti-EPAS1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB1405933
Anti-HIF1A antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA001275
Anti-HIF1A antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2101039
Anti-HIF1A antibody produced in rabbit, affinity isolated antibody
SAB2104366
Anti-HIF1A antibody produced in rabbit, affinity isolated antibody
SAB2702132
Anti-HIF1A antibody produced in rabbit
SAB2105451
Anti-MGMT antibody produced in rabbit, affinity isolated antibody
HPA007007
Anti-NES antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA026111
Anti-NES antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104575
Anti-NES antibody produced in rabbit, affinity isolated antibody
PLA0304
Goat anti-HIF1-alpha Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
SAB5200017
Monoclonal Anti-HIF-1 α antibody produced in mouse, clone ESEE122, 1 mg/mL, purified immunoglobulin
H6536 Monoclonal Anti-HIF-1α antibody produced in mouse, ~1 mg/mL, clone H1α67, purified immunoglobulin, buffered aqueous solution
H6411 Monoclonal Anti-HIF-1α antibody produced in mouse, ~1 mg/mL, clone OZ12, purified immunoglobulin, buffered aqueous solution
PLA0081
Rabbit anti-HIF1-alpha Antibody, Affinity Purified, Powered by Bethyl Laboratories, Inc.
V-011
Retinol solution, 100 μg/mL ± 25% (Refer to COA) (Ethanol with 0.1% (w/v) BHT), ampule of 1 mL, certified reference material
C20H30O